Can a Two-Drug combo stop nerve tumors from turning cancerous?
Disease control
Recruiting now
This trial is testing whether combining two drugs—selumetinib and APG-115—can help people with neurofibromatosis type 1 (NF1) who have nerve sheath tumors that are either pre-cancerous or already cancerous. The study aims to find a safe dose and see if the combination can shrink …
Phase: PHASE1, PHASE2 • Sponsor: AeRang Kim • Aim: Disease control
Last updated Jul 29, 2026 00:00 UTC